11.Tsushima H，Kawata S，TamuraS，et al.Reduced Plasma transforming growth factor-beta levels in patients with chronichepatitis after inferferon-alpha therapy：association with regression of hepaticfibrosis.J hepatol，1999，30：1.
22.Koda M，Murawaki Y，Kawaski H，et al.Portal blood velocity and portal blood flow inpatients with chronic viral hepatitis，relation to histological liverfibrosis.Hepatogastroenterology，1996，43：199.
33.Alanen A，Komu M，Leino R，et al.MR and magnetisation transfer imaging in cirrhoticand fatly livers.Acta.Radiol，1998，39：439.
44.Christophe P，Marie CR，Pierre B，et al.Histopathological evalution of liver fibrosis：quantitativeimage analysis vs semi-quantitative sore.J Hepatol，1998，28：439.
55.Chevallier M，Guerret S，Chossegros P，et al.A histological semiquantitative scoringsystem for evaluation of hepatic fibrosis in needle liver biopsy specimens：comparisonwith morphometric studies.Hepatology，1994，20：349.
66.Dioguardi N，Grizzi F，Bossi P，et al.Fractal and spectral dimension analysis ofliver fibrosis in needle biopsy specimens.Anal.Quant.Cytol.Histol，1999，21：262.
88.Araujo MS，Guerret S.Gerard F，et al.Quantitative studies on liver fibrosis，andalpha-smooth muscle actin expression in heroin abusers.Cell Mol.Biol，1997，20：1310.
99.Rimura K，Ando K，Ohnishi H，et al.Immunopathogenesis of hepatic fibrosis in chronicliver injury induced by repeatedly administered concanavalin A.Int.Immunol，1999，11：1491.
1010.Murawaiki Y，Ikuta Y，Idobe Y，et al.Tissue inhibitor of metalloproteinases-1 in theliver of patients with chronic liver disease.J Hepatol，1997，26：1213.
（2000-05-30收稿）
1Montilla P,Cruz A,Padillo F J,et al.Melatonin Versus Vitamin E,as Protective treatment against oxidative Stress after extra-hepatic bile duct ligation in rats.JVIPinea/Res,2001,31:138.
